Associate Director (M/F/X), Real World Evidence (Rwe) Science

Csl; Maidenhead; On-site; GBP 120,000 - 180,000; Full time

Benefits offered by this job

Competitive compensation

Comprehensive benefits package

Flexible working arrangements

Job summary

CSL Seqirus seeks an Associate Director (m/f/x) in Real World Evidence Science to lead global RWE programs within CORE, shaping strategy for late-stage and marketed vaccines. You will work across Medical Affairs, R&D, Market Access, and Regulatory affairs to generate evidence informing clinical practice and health authority engagement.

Reporting to the Senior Director, you will oversee complex studies, manage CROs, and contribute to publications, conferences, and policy discussions while

Qualifications

• Advanced epidemiology/outcomes research knowledge.
• Experience designing and executing prospective and retrospective RWE studies.
• Strong publication and presentation track record.

Responsibilities

• Lead global RWE studies across vaccine programs.
• Oversee feasibility, protocol development, and study reports.
• Collaborate with Medical Affairs, Market Access, Regulatory, and CROs.

Skills

Epidemiology expertise

Biostatistics

Cross-functional leadership

Scientific communication

Education

MD, PhD, or Master’s in Epidemiology/Related field

Tools

SAS

SQL

R

Stata

Job description

Associate Director (m/f/x), Real World Evidence (RWE) Science

Location: Amsterdam, Maidenhead, Munich

The Opportunity

Join Seqirus and play a pivotal role in shaping the future of real-world evidence generation in vaccines. As Associate Director, RWE Science, you will be a senior scientific leader within the Center of Outcomes Research and Epidemiology (CORE), driving the development and execution of global real-world research strategies that support late-stage and marketed vaccine products.

Working across a highly matrixed global environment, you will collaborate with Medical Affairs, R&D, Market Access, Regulatory Affairs, Commercial teams, and external scientific stakeholders to generate impactful evidence that informs clinical practice, supports health authority engagement, and strengthens public health outcomes worldwide.

The Role

Reporting to the Senior Director, Center of Outcomes Research and Epidemiology (CORE), you will provide scientific and methodological leadership for global real-world evidence programs and help shape the short- to medium-term RWE strategy.

Key responsibilities include:

• Lead the planning, design, execution, and oversight of complex real-world evidence (RWE) studies across multiple vaccine programs.
• Support the development and implementation of the global RWE research plan and broader Seqirus Medical Affairs strategy.
• Collaborate cross-functionally with Medical Affairs, Market Access, Clinical Development, Regulatory Affairs, Commercial, Health Policy, and other key stakeholders.
• Oversee feasibility assessments, protocol development, study reports, and evidence packages supporting registration and reimbursement activities.
• Manage internal and external research resources, including CROs and scientific partners, to ensure high-quality study execution.
• Contribute to health authority interactions, scientific publications, conference presentations, and dissemination of evidence to key stakeholders.
• Ensure compliance with applicable regulatory, pharmacovigilance, and company requirements.
• Build and maintain relationships with academic institutions, key opinion leaders, vaccine advisory bodies, and external scientific organizations.
• Foster a high-performing, collaborative environment that encourages scientific excellence and innovation.

Your Qualifications

To succeed in this role, you will bring strong scientific expertise, strategic thinking, and the ability to influence stakeholders across global functions.

Required Qualifications

• MD, PhD, or Master's degree in Epidemiology, Biostatistics, Public Health, or a related health sciences discipline.
• 8–10 years of progressive epidemiology or outcomes research experience, including at least 5 years within the pharmaceutical or biotechnology industry.
• Demonstrated experience designing, implementing, and analyzing prospective epidemiologic studies and retrospective analyses using large healthcare databases.
• Strong expertise in Phase IV and outcomes research methodologies.
• Experience working with real-world data sources, including claims databases and electronic medical records.
• Proficiency with statistical and analytical tools such as SAS, SQL, R, and/or Stata.
• Proven scientific publication record and strong presentation skills.
• Experience leading complex cross-functional projects in a global environment.
• Excellent communication, stakeholder management, and project leadership capabilities.

Preferred Competencies

• Ability to translate complex scientific findings into actionable insights for diverse audiences.
• Strategic mindset with strong problem-solving and decision-making skills.
• Experience influencing senior internal and external stakeholders.
• Ability to work effectively in a highly matrixed global organization.
• Passion for advancing evidence generation to improve public health outcomes.

What We Offer

At Seqirus, you'll have the opportunity to contribute to a global mission focused on protecting public health through innovative vaccine solutions. You'll work alongside highly experienced scientific and medical professionals in a collaborative environment that values innovation, development, and scientific excellence.

We offer:

• Meaningful work with global impact.
• Opportunities to shape evidence-generation strategy for market-leading vaccine products.
• A highly collaborative and international work environment.
• Professional development and leadership opportunities.
• Competitive compensation and comprehensive benefits package.
• Flexible working arrangements where applicable.

Join us in advancing science, improving patient outcomes, and helping protect communities worldwide.

About CSL Seqirus

CSL Seqirus is part of CSL. As one of the largest influenza vaccine providers in the world, CSL Seqirus is a major contributor to the prevention of influenza globally and a transcontinental partner in pandemic preparedness. With state-of-the-art production facilities in the U.S., the U.K. and Australia, CSL Seqirus utilizes egg, cell and adjuvant technologies to offer a broad portfolio of differentiated influenza vaccines in more than 20 countries around the world.

To learn more about CSL, CSL Behring, CSL Seqirus and CSL Vifor visit and CSL Plasma at .

Our Benefits